Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
Top Cited Papers
- 8 October 2006
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 38 (11) , 1239-1241
- https://doi.org/10.1038/ng1902
Abstract
We identified constitutional truncating mutations of the BRCA1-interacting helicase BRIP1 in 9/1,212 individuals with breast cancer from BRCA1/BRCA2 mutation–negative families but in only 2/2,081 controls (P = 0.0030), and we estimate that BRIP1 mutations confer a relative risk of breast cancer of 2.0 (95% confidence interval = 1.2–3.2, P = 0.012). Biallelic BRIP1 mutations were recently shown to cause Fanconi anemia complementation group J. Thus, inactivating truncating mutations of BRIP1, similar to those in BRCA2, cause Fanconi anemia in biallelic carriers and confer susceptibility to breast cancer in monoallelic carriers.Keywords
This publication has 13 references indexed in Scilit:
- ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility allelesNature Genetics, 2006
- Molecular pathogenesis of Fanconi anemia: recent progressBlood, 2006
- BACH1 is a DNA repair protein supporting BRCA1 damage responseOncogene, 2006
- Assessing the Link between BACH1 and BRCA1 in the FA PathwayCell Cycle, 2005
- The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemiaNature Genetics, 2005
- The DNA helicase BRIP1 is defective in Fanconi anemia complementation group JNature Genetics, 2005
- Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumourJournal of Medical Genetics, 2005
- Biallelic Inactivation of BRCA2 in Fanconi AnemiaScience, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based studyGenetic Epidemiology, 2001